Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Biomarker Changes during 20 Years Preceding Alzheimer’s Disease

Abstract

Background Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer's disease have not been extensively investigated in longitudinal studies. Methods We conducted a multicenter, nested case-control study of Alzheimer's disease biomarkers in cognitively normal participants who were enrolled in the China Cognition and Aging Study from January 2000 through December 2020. A subgroup of these participants underwent testing of cerebrospinal fluid (CSF), cognitive assessments, and brain imaging at 2-year-to-3-year intervals. A total of 648 participants in whom Alzheimer's disease developed were matched with 648 participants who had normal cognition, and the temporal trajectories of CSF biochemical marker concentrations, cognitive testing, and imaging were analyzed in the two groups. Results The median follow-up was 19.9 years (interquartile range, 19.5 to 20.2). CSF and imaging biomarkers in the Alzheimer's disease group diverged from those in the cognitively normal group at the following estimated number of years before diagnosis: amyloid-beta (Aβ) 42 , 18 years; the ratio of Aβ 42 to Aβ 40 , 14 years; phosphorylated tau 181, 11 years; total tau, 10 years; neurofilament light chain, 9 years; hippocampal volume, 8 years; and cognitive decline, 6 years. As cognitive impairment progressed, the changes in CSF biomarker levels in the Alzheimer's disease group initially accelerated and then slowed. Conclusions In this study involving Chi…

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmoa2310168

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 488

Metadata

Authors
Jia, J., Ning, Y., Chen, M., Wang, S., Yang, H., Li, F., Ding, J., Li, Y., Zhao, B., Lyu, J., Yang, S., Yan, X., Wang, Y., Qin, W., Wang, Q., Li, Y., Zhang, J., Liang, F., Liao, Z., & Wang, S.
Affiliations
  • Capital Medical University (CN)
  • From the Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital (J.J., Y.N., M.C., Shuheng Wang, H.Y., F. Li, J.D., Yan Li, B.Z., W.Q., Q.W., Ying Li), Beijing Key Laboratory of Geriatric Cognitive Disorders, Clinical Center for Neurodegenerative Disease and Memory Impairment (J.J.), the Center of Alzheimer’s Disease, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders (J.J.), and the Department of Neurology, Beijing Anding Hospital (Y.W.), Capital Medical University, Key Laboratory of Neurodegenerative Diseases, Ministry of Education (J.J.), the Center for Cognitive Disorders, Beijing Geriatric Hospital (J.L.), and the Department of Neurology, Beijing Jishuitan Hospital (X.Y.), Beijing, the Department of Neurology, Daqing Oilfield General Hospital, Daqing (S.Y.), the Department of Neurology, the 960th Hospital of the People’s Liberation Army, Jinan (J.Z.), the Department of Neurology, Baotou Central Hospital, Baotou (F. Liang), the Depa...
Venue
New England Journal of Medicine
Published
2024-02-22
Volume
390
Issue
8
Pages
712-722
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4391990232
Cited by
455
References
33
Citations by year
2026: 162 · 2025: 202 · 2024: 91
FWCI
133.16
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (30370494, 30410303095, 30470615)
  • Mission Program of Beijing Municipal Administration of Hospitals (SML20150801)
  • Beijing Natural Science Foundation (7071004)
  • The National Science and Technology Foundation of China (2003CB517102, 2004BA714B06-1, 2006BAI02B01, 2006CB500700, 2011CB504101, 2011ZX09307-001-03)
  • Sailing Plan of Beijing Municipal Administration of Hospitals (ZY201301)
  • Major project of Beijing Municipal Science and Technology Commission (D111107003111009)
  • Beijing Brain Initiative from Beijing Municipal Science & Technology Commission (Z201100005520017, Z161100000216137, Z201100005520016)
  • Key Project of the National Natural Science Foundation of China (81530036, U20A20354)
  • National Key Scientific Instrument and Equipment Development Projects of China (31627803)
  • National major R&D projects of China-Scientific technological innovation 2030 (2021ZD0201802)
  • CHINACANADA Joint Initiative on Alzheimer’s Disease and Related Disorders (81261120571)
  • Beijing Scholars Program
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords
Alzheimer's disease, preclinical Alzheimer's disease, cerebrospinal fluid biomarkers, amyloid-beta 42, phosphorylated tau 181, total tau, neurofilament light chain, hippocampal volume, cognitive decline, sporadic Alzheimer's disease
MeSH terms
Alzheimer Disease, Follow-Up Studies, Humans, Biomarkers, Case-Control Studies, Amyloid beta-Peptides, tau Proteins, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.